Has the pandemic helped transform how we address other illnesses and therapies? with Hisham Hamadeh
The Data Standard
Has the pandemic helped transform how we address other illnesses and therapies? with Hisham Hamadeh
Hisham Hamadeh, Vice President, Global Head of Data Science at Genmab, sits down with TDS to discuss ways that the pandemic might have helped transform how we identify and commercialize treatments for other illnesses.
Episode Summary
The COVID-19 pandemic and the resulting stay-at-home orders have led to significant changes in the way people work. One of these changes involves the increased use of video conferencing as a means of communicating or holding work meetings. In this episode, guest Hisham Hamadeh sits down with TDS to discuss ways that the pandemic might have helped transform how we identify and commercialize treatments for other illnesses.
Meet The Host
Darren Kaplan
Co-Founder & Board Member of HiQ Labs
Darren Kaplan is 2x Founder and recognized as one of the Top 20 Data Science Influencers in 2020. Darren is the co-creator of The Data Standard, the premier networking user-community for data-science, data engineers, and cybersecurity enthusiasts.
Meet The Guest
Hisham Hamadeh
Vice President, Global Head of Data Science at Genmab
Experienced biotechnology executive with a unique background in R&D and commercial. Strong background in Drug Discovery and Development, Data Science, and Beyond the Molecule Innovation.
